GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

Andrew Witty has now gone, with Emma Walmsley commencing ... She has pledged to make tough decisions wherever necessary, however, and says GSK must step up its search for new blockbusters to ...

The resignation comes after the company's poor performance in the first quarter of 2025. Where to invest $1,000 right ...

Andrew Wright is a Newsweek contributor based in Lancaster, South Carolina. His focus is MLB content. Andrew has been with Newsweek since April 1st and previously worked at Yardbarker, SEC ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.